| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,355 | 2,645 | 2,764 | 4,525 | | Cost of Revenue | (7,631) | 4,659 | 2,972 | 4,235 | | | Gross Profit | 9,986 | (2,014) | (208) | 289 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 10,668 | 1,593 | 1,477 | 1,315 | | Non Recurring | 4,967 | 2,368 |
-
|
-
| | Others | 385 | 415 | 407 | 1,096 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,067) | (6,391) | (2,091) | (2,122) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,388) | (988) | (2,923) | (2,109) | | Earnings Before Interest And Taxes | (1,067) | (6,391) | (2,091) | (2,122) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (1,067) | (6,391) | (2,091) | (2,122) | | Income Tax Expense | (36) | (156) | (16) | (156) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,880 | (7,223) | (4,998) | (4,074) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,419) | (7,223) | (4,998) | (4,074) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,419) | ($7,223) | ($4,998) | ($4,074) |
|
0.51% Nasdaq 
Income Statement
